MarketsandMarkets, organizer of The High Potent Medicines Conference, is pleased to announce that Juergen Knoebel, Head – Small Molecules Quality Operations, F.Hoffmann La Roche AG, Switzerland has
Inato has raised $20 million in early-stage financing to support the continued development of its clinical trial marketplace, which connects sponsors with its network of t